BioSpace News Archive

OncoSec Medical Incorporated (NASDAQ: ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral cancer immunotherapies, today announced that its Board of Directors (the “Board”) has determined the Alpha Holdings, Inc. (“Alpha”) proposal conveying a preliminary financing offer is not in the best interests of all shareholders.

Premier Anesthesia, a national anesthesia management and consulting company, recently announced that it was selected by and is providing anesthesia management services to Eastside Medical Center in Snellville, Georgia.

APD418 currently in Phase 1 clinical investigation - data expected this year

Study is evaluating the safety/tolerability of BTX-A51 in patients with relapsed/refractory acute myeloid leukemia (AML), as well as high risk myelodysplastic syndrome patients.

This is Welldoc’s 8th 510(k) filing to the U.S. Food and Drug Administration

The event will display the most exciting products coming out of CES 2020 and host a panel of leading technology experts to discuss the newest trends in today’s world of consumer technology.

Dr. Brush joined the Frazier Life Sciences team in 2016 and focuses on investments in public biopharma companies in addition to private deals.

Kim brings nearly two decades of experience in law and health policy as a former congressional advisor and health care advocate.

The combined effort is to further promote PCT Corp.’s Annihilyzer® Infection Control Systems being deployed more quickly and to obtain more growth in this market.

Incubator housed within the Allen Institute for AI will leverage expanded resources to help entrepreneurs launch AI-first startups